摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1H-1,2,3-triazol-1-yl)phenol

中文名称
——
中文别名
——
英文名称
2-(1H-1,2,3-triazol-1-yl)phenol
英文别名
2-(1,2,3-triazol-1-yl)phenol;N-hydroxy-phenyl-triazole;2-(Triazol-1-yl)phenol
2-(1H-1,2,3-triazol-1-yl)phenol化学式
CAS
——
化学式
C8H7N3O
mdl
——
分子量
161.163
InChiKey
ZNPUGXGQPUWUSK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    50.9
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-(1H-1,2,3-triazol-1-yl)phenolpotassium phosphatetris-(dibenzylideneacetone)dipalladium(0)potassium carbonate4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下, 以 1,4-二氧六环N,N-二甲基甲酰胺 为溶剂, 反应 32.0h, 生成 4-[2-(1H-1,2,3-triazol-1-yl)phenyloxy]-N-(2-methoxy-5-(4-methylpiperazin-1-yl)phenyl)-5-methylpyrimidin-2-amine
    参考文献:
    名称:
    一种2-芳香胺基嘧啶类化合物及其制备方法与应用
    摘要:
    本申请涉及生物医药技术领域,具体公开了一种2‑芳香胺基嘧啶类化合物及其制备方法与应用。本申请提供一种2‑芳香胺基嘧啶类化合物,该化合物为通式I所示的化合物或其药学上可接受的盐、异构体、溶剂化物、水合物、前药或同位素衍生物;通式I的结构式为:#imgabs0#本申请提供的2‑芳香胺基嘧啶类化合物对PLK1的活性具有很强的抑制作用,有望开发成为新型抗肿瘤药物。
    公开号:
    CN117800953A
  • 作为产物:
    描述:
    3-氯-1,4-苯并恶嗪-2-酮 作用下, 以 乙醚氯苯乙腈 为溶剂, 反应 96.0h, 生成 2-(1H-1,2,3-triazol-1-yl)phenol
    参考文献:
    名称:
    通过3(,5)-(di)chloro-2 H -1,4-(benz)oxazin-2-ones与叠氮化钠或重氮化合物的反应合成新的1 H-四唑和1,2,3-三唑
    摘要:
    3,5-dichloro-2 H -1,4-oxazin-2-ones和3-chloro-2 H -1,4-benzoxazin-2-ones与叠氮化钠和重氮化合物等双功能试剂反应生成bi(tri环四唑或三唑稠合的中间体通过分子内环化反应。这些内酯中间体与各种亲核试剂的转化产生了新的取代的1 H-四唑或1,2,3-三唑,可用于药理筛选以及通过N-1处的α-氯酮取代基进一步加工。
    DOI:
    10.1016/0040-4020(96)00423-1
点击查看最新优质反应信息

文献信息

  • HSP90 INHIBITING INDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF
    申请人:Bertin Luc
    公开号:US20120010241A1
    公开(公告)日:2012-01-12
    The invention relates to novel products having formula (I), wherein: R4 represents H, CH3, CH2CH3, CF3, F, Cl, Br, I; Het represents a heterocycle optionally substituted by one or more R1 or R′1 radicals selected from H, halogen, CF3, nitro, cyano, alkyl, hydroxy, mercapto, amino, alkylamino, dialkylamino, alkoxy, phenylalkoxy, alkylthio, carboxy that is free or sterified with an alkyl radical, carboxamide, CO—NH(alkyl), CON(alkyl)2, NH—CO-alkyl, sulfonamide, NH—SO2-alkyl, S(O)2-NHalkyl, S(O2)-N(alkyl)2, all of the alkyl, alkoxy and alkylthio radicals being optionally substituted; R being selected from the group comprising (A′), (B), (C), (D) and (F), wherein W1, W2, W3 represent independently CH or N, X represents O, S, NR2, C(O), S(O) or S(O)2; V represents H, Hal, —O—R2 or —NH—R2 with R2 representing H, alkyl, cycloalkyl or heterocycloalkyl, optionally substituted; said products being in all isomer forms, as well as the salts and intended for use as drugs.
    本发明涉及具有公式(I)的新产品,其中:R4代表H,CH3,CH2CH3,CF3,F,Cl,Br,I;Het代表一个杂环,可选地由一个或多个R1或R'1自由基取代,这些自由基选自H,卤素,CF3,硝基,腈基,烷基,羟基,巯基,氨基,烷基氨基,二烷基氨基,烷氧基,苯基烷氧基,烷基硫醚,游离或与烷基自由基酯化的羧基,羧酰胺,CO—NH(烷基),CON(烷基)2,NH—CO-烷基,磺酰胺,NH—SO2-烷基,S(O)2-NH烷基,S(O2)-N(烷基)2,所有烷基,烷氧基和烷基硫醚自由基都是可选取代的;R选自包括(A′),(B),(C),(D)和(F)的组,其中W1,W2,W3独立代表CH或N,X代表O,S,NR2,C(O),S(O)或S(O)2;V代表H,Hal,—O—R2或—NH—R2,R2代表H,烷基,环烷基或杂环烷基,可选取代;所述产品为所有异构体形式,以及盐,用于作为药物使用。
  • NOVEL HSP90 INHIBITORY CARBAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF
    申请人:RUXER Jean-Marie
    公开号:US20110166169A1
    公开(公告)日:2011-07-07
    The invention relates to the novel substances in Formula (I): wherein Het is a heterocycle optionally substituted by one or a plurality of radicals R1 or R′1; R is selected from the group comprising Formula (A′), (B), (C), (D), or (E), with R1 and/or R′1 selected from H, halogen, CF3, nitro, cyano, alkyl, hydroxyl, mercapto, amino, alkylamino, dialkylamino, alkoxy, phenylalcoxy, alkylhio, or carboxy that is free or esterified by an alkyl, carboxamide, CO—NH(alkyl), CON(alkyl)2, NH—CO-alkyl, sulfonamide, NH—S02-alkyl, S(0)2-NHalkyl, or S(02)-N(alkyl)2 radical; all these radicals are optionally substituted; W1, W2, and W3 independently are CH or N; X is 0, S, NR2, C(O), S(O), or S(0)2; Z is optionally substituted H, Hal, -0-R2 or —NH—R2 with R2 being H, alkyl, cycloalkyl, or heterocycloalkyl; and these substances are all isomeric forms and salts thereof, used as drugs.
    该发明涉及式(I)中的新物质:其中Het是一种杂环,可选择地由一个或多个基团R1或R′1取代;R从包括式(A′)、(B)、(C)、(D)或(E)的基团中选择,其中R1和/或R′1从H、卤素、CF3、硝基、氰基、烷基、羟基、巯基、氨基、烷基氨基、二烷基氨基、烷氧基、苯基氧基、烷硫基或自由或被烷基、羧酰胺、CO—NH(烷基)、CON(烷基)2、NH—CO-烷基、磺酰胺、NH—S02-烷基、S(0)2-NH烷基或S(02)-N(烷基)2基团中选择;所有这些基团可选择地被取代;W1、W2和W3独立地是CH或N;X是0、S、NR2、C(O)、S(O)或S(0)2;Z是可选择地取代的H、卤素、-0-R2或—NH—R2,其中R2是H、烷基、环烷基或杂环烷基;这些物质都是同分异构体和其盐,用作药物。
  • An azide and acetylene free synthesis of 1-substituted 1,2,3-triazoles
    作者:Sarah J.M. Patterson、Peter R. Clark、Glynn D. Williams、Nicholas C.O. Tomkinson
    DOI:10.1016/j.tetlet.2020.152483
    日期:2020.11
    This paper details a simple and efficient 3-component synthesis of 1-substituted 1,2,3-triazoles using a primary amine, 2,2-dimethoxyacetaldehyde and tosylhydrazide. The reaction proceeds in good to excellent yields using either aliphatic or aromatic amine substrates and is tolerant of a wide range of functional groups including electron-rich and deficient aryl groups, terminal alkynes, ketones and
    本文详细介绍了一种使用伯胺,2,2-二甲氧基乙醛和甲苯磺酰肼的简单高效的1取代1,2,3-三唑的3组分合成方法。使用脂族或芳族胺底物,该反应以良好的产率进行,并且耐受多种官能团,包括富电子和不足的芳基,末端炔烃,酮和高度位阻的胺。
  • NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF
    申请人:Alasia Marcel
    公开号:US20110184015A1
    公开(公告)日:2011-07-28
    Pyrroloindoles of formula (I) are provided wherein Het is an aromatic or partially unsaturated, monocyclic or bicyclic heterocycle containing between 1 and 4 heteroatoms N, O or S, optionally substituted by R1 or R′1 which are the same or different; R is X-(A-B)n-CONH2, X-(A-B)n-O—CONH2, X-(A-B)n-NH—CONH2, X—(CH2)m-heterocycloalkyl, X(CH2)m-aryl and X—(CH2)m-heteroaryl wherein X is —O—C(O), —NH—C(O), NH—CS, —NH—CO—CH2-O—; —NH—COCH2-S—CH2-CO—NH—; —NH—CO—(CH2)2-SO2-; and —NH—CO—CH2-N(CH3)-CO—; A and B are the same or different and are each independently a single bond, CH2, CH-alkyl, and CH-aralkyl; n=1,2 and m=0, 1; R1 and/or R′1 are H, halogen, CF3, nitro, cyano, alkyle, hydroxy, mercapto, amino, alkylamino, dialkylamino, alkoxy, alkylthio, and carboxy, free or esterified by an alkyl, carboxamide, CONH(alkyl), CON(alkyl)2, NH—CO-alkyl, sulfonamide, NH—SO2-alkyl, S(O)2-NHalkyl, and S(O2)-N(alkyl)2 group, all of said alkyl, alcoxy and alkylthio groups being optionally substituted themselves, said products being in all isomer forms and salts, as medicaments.
    提供了式(I)的吡咯吲哚,其中Het是含有1至4个杂原子N、O或S的芳香或部分不饱和的单环或双环杂环,可以由R1或R′1取代,它们可以相同也可以不同;R是X-(A-B)n-CONH2,X-(A-B)n-O—CONH2,X-(A-B)n-NH—CONH2,X—(CH2)m-杂环烷基,X(CH2)m-芳基和X—(CH2)m-杂芳基,其中X是—O—C(O),—NH—C(O),NH—CS,—NH—CO—CH2-O—;—NH—COCH2-S—CH2-CO—NH—;—NH—CO—(CH2)2-SO2-;和—NH—CO—CH2-N(CH3)-CO—;A和B相同或不同,分别是单键,CH2,CH-烷基和CH-芳烷基;n=1,2,m=0,1;R1和/或R′1是H,卤素,CF3,硝基,氰基,烷基,羟基,巯基,氨基,烷基氨基,二烷基氨基,烷氧基,烷基硫基和羧基,均为自由或被烷基、羧酰胺、CONH(烷基)、CON(烷基)2、NH—CO-烷基、磺酰胺、NH—SO2-烷基、S(O)2-NH烷基和S(O2)-N(烷基)2基酯化的,所述的所有烷基、烷氧基和烷基硫基基团本身也可以被取代,所述产品以所有异构体形式和盐形式作为药物。
  • 3-hydroxy-cyclohex-2-enone based azo dyes, and their use with anionic azo metal complex dyes
    申请人:Clariant International Ltd.
    公开号:EP1925642A1
    公开(公告)日:2008-05-28
    The present invention relates to the use of 3-hydroxy-cyclohex-2-enone azo based dyes and/or of azo metal complex dyes made thereof, and to compositions comprising 3-hydroxy-cyclohex-2-enone azo based dyes and anionic azo metal complex dyes with cationic basic yellow dyes in optical layers for optical data recording, preferably for optical data recording using a laser with a wavelength up to 450 nm. The invention further relates to a write once read many (WORM) type optical data recording medium capable of recording and reproducing information with radiation of blue laser, which employs a 3-hydroxy-cyclohex-2-enone azo based dye and/or an azo metal complex dye made thereof, or a composition comprising a 3-hydroxy-cyclohex-2-enone azo based dye and a anionic azo metal complex dye with a cationic basic yellow dye in the optical layer.
    本发明涉及使用3-羟基环己-2-烯酮偶氮基染料和/或由此制成的偶氮金属络合物染料,以及包含3-羟基环己-2-烯酮偶氮基染料和带有阳离子基本黄染料的阴离子偶氮金属络合物染料的组合物,在光学层中用于光学数据记录,最好用于使用波长高达450纳米的激光进行光学数据记录。该发明还涉及一种一次写多次读(WORM)型光学数据记录介质,能够使用蓝激光记录和复制信息,该介质采用3-羟基环己-2-烯酮偶氮基染料和/或由此制成的偶氮金属络合物染料,或者包含3-羟基环己-2-烯酮偶氮基染料和光学层中的带有阳离子基本黄染料的阴离子偶氮金属络合物染料的组合物。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺